Kate Lapane to Off-Label Use
This is a "connection" page, showing publications Kate Lapane has written about Off-Label Use.
Connection Strength
0.699
-
Tjia J, Reidenberg MM, Hunnicutt JN, Paice K, Donovan JL, Kanaan A, Briesacher BA, Lapane KL. Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia. Consult Pharm. 2015 Oct; 30(10):599-611.
Score: 0.512
-
Lapane KL. Reducing Off-Label Antipsychotic Use in Older Adults: Time to Look Beyond the Doors of Nursing Homes. J Am Geriatr Soc. 2018 07; 66(6):1055-1057.
Score: 0.150
-
Maxwell CJ, Campitelli MA, Hogan DB, Diong C, Austin PC, Amuah JE, Lapane K, Seitz DP, Gill SS, Gruneir A, Wodchis WP, Bronskill SE. Relevance of frailty to mortality associated with the use of antipsychotics among community-residing older adults with impaired cognition. Pharmacoepidemiol Drug Saf. 2018 03; 27(3):289-298.
Score: 0.037